Profile | GDS2987 / GI_31340723-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 0.3 | 1 |
GSM215244 | HMVEC_vehicle_rep2 | 7.9 | 20 |
GSM215253 | HMVEC_vehicle_rep3 | 18.2 | 50 |
GSM215254 | HMVEC_atorvastatin_rep1 | 13.9 | 35 |
GSM215282 | HMVEC_atorvastatin_rep3 | 21.1 | 44 |
GSM215344 | HMVEC_atorvastatin_rep2 | 17.5 | 40 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 13.9 | 27 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 34.6 | 55 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 23.8 | 37 |
GSM215294 | HMVEC_SLx2119_rep1 | 5 | 19 |
GSM215295 | HMVEC_SLx2119_rep2 | 8 | 17 |
GSM215296 | HMVEC_SLx2119_rep3 | 56.3 | 64 |
GSM215297 | PASMC_vehicle_rep1 | 52 | 60 |
GSM215298 | PASMC_vehicle_rep2 | 94.2 | 73 |
GSM215310 | PASMC_vehicle_rep3 | 43.3 | 56 |
GSM215311 | PASMC_atorvastatin_rep1 | 57.4 | 66 |
GSM215312 | PASMC_atorvastatin_rep2 | 79.5 | 71 |
GSM215313 | PASMC_atorvastatin_rep3 | 16.7 | 25 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 25.5 | 40 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 56 | 66 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 30.7 | 47 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | 53.5 | 65 |
GSM215329 | PASMC_SLx2119_rep3 | 39.2 | 58 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | 15 | 39 |
GSM215332 | Fibroblasts_vehicle_rep3 | 13.9 | 42 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | ||
GSM215334 | Fibroblasts_atorvastatin_rep2 | 12.9 | 35 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 18.1 | 41 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 22.8 | 57 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 17.4 | 48 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 17.5 | 44 |
GSM215339 | Fibroblasts_SLx2119_rep1 | ||
GSM215340 | Fibroblasts_SLx2119_rep2 | 28.6 | 59 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 17 | 40 |